Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Perspectives and new aspects of histone deacetylase inhibitors in the therapy of CNS diseases
Bo Han, Mengfei Wang, Jiayi Li, et al.
European Journal of Medicinal Chemistry (2023) Vol. 258, pp. 115613-115613
Closed Access | Times Cited: 14

Showing 14 citing articles:

Restoring the epigenome in Alzheimer's disease: advancing HDAC inhibitors as therapeutic agents
Márcia S. Pereira, Maria Teresa Cruz, Ana Fortuna, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 7, pp. 104052-104052
Open Access | Times Cited: 7
A method for HDAC activity screening in postmortem human brain. A proof-of-concept study with antipsychotics
Oihane Martínez-Peula, Alfredo Ramos‐Miguel, Carolina Muguruza, et al.
Journal of Neuroscience Methods (2025), pp. 110365-110365
Closed Access
Design and Synthesis of Novel Piperidine Urea Derivatives with Neuroprotective Properties
Jiayi Li, Mengfei Wang, Ling Jiang, et al.
Pharmaceutical Fronts (2025)
Open Access
Design, synthesis, and anticancer evaluation of alkynylated pyrrole derivatives
Hegeng Wei, Yu Cao, Chungang Zhao, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 2
Closed Access | Times Cited: 3
Empirical Analysis of Drug Targets for Nervous System Disorders
Louis G. Mueller, Barbara S. Slusher, Takashi Tsukamoto
ACS Chemical Neuroscience (2024) Vol. 15, Iss. 3, pp. 394-399
Closed Access | Times Cited: 2
Discovery of a novel hybrid coumarin-hydroxamate conjugate targeting the HDAC1-Sp1-FOSL2 signaling axis for breast cancer therapy
Sujie Zhu, Wenjing Zhu, Kaihua Zhao, et al.
Cell Communication and Signaling (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 2
Recent Molecular Targets and Their Ligands for the Treatment of Alzheimer Disease
Gülşah Bayraktar, Vildan Alptüzün
Current Topics in Medicinal Chemistry (2024) Vol. 24, Iss. 28, pp. 2447-2464
Closed Access | Times Cited: 1
Epigenetic Biomarkers in Alzheimer's Disease: Diagnostic and Prognostic Relevance
Tapan Behl, Ashishkumar Kyada, R Roopashree, et al.
Ageing Research Reviews (2024) Vol. 102, pp. 102556-102556
Closed Access | Times Cited: 1
Modifications épigénétiques dans l’addiction à l’alcool et perspectives thérapeutiques
Olivier Pierrefiche
Bulletin de l Académie Nationale de Médecine (2024) Vol. 208, Iss. 4, pp. 451-458
Closed Access
Design, synthesis and neuroprotective biological evaluation of novel HDAC6 inhibitors incorporating benzothiadiazinyl systems as cap groups
Bo Han, Xiu Gu, Mengfei Wang, et al.
Chemical Biology & Drug Design (2024) Vol. 103, Iss. 5
Closed Access
Design, Synthesis, and Biological Evaluation of HDAC Inhibitors Containing Natural Product-Inspired N-Linked 2-Acetylpyrrole Cap
Han Zhang, Qianqian Shen, Hu Zhu, et al.
Molecules (2024) Vol. 29, Iss. 19, pp. 4653-4653
Open Access
Modifications épigénétiques dans l’addiction à l’alcool et perspectives thérapeutiques
Olivier Pierrefiche
Annales Pharmaceutiques Françaises (2024)
Closed Access
An Improved Synthesis Process of Ricolinostat: The First Orally Selective HDAC6 Inhibitor
Mengfei Wang, Niubing Sun, Qiushi Chen, et al.
Pharmaceutical Fronts (2024)
Open Access
A novel histone deacetylase inhibitor protects the blood-brain barrier by regulating NF-κB and Nrf2 signaling pathways in OGD/R injury
Ling Lu, Guoyang Zhou, Xun Zhang, et al.
Archives of Gerontology and Geriatrics (2024) Vol. 131, pp. 105739-105739
Closed Access
Page 1

Scroll to top